Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children
Clinical trial NCT00307021 · COMPLETED
Trial details
- NCT number
- NCT00307021
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-07
- Primary completion
- 2006-09-15
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.